The Wild West of Fertility Clinics
By Madeline Verniero,
The Regulatory Review
| 08. 10. 2021
As of 2018, in vitro fertilization (IVF) has resulted in the births of approximately 8 million babies. IVF has also created a lucrative industry in fertility services.
But this industry poses risks that remain unregulated, argue law professor Steve Calandrillo and lawyer Chryssa Deliganis. The lack of regulation has led to a “wild West” mentality in fertility clinics, where “cash is king and informed consent is optional.” With minimal regulations and hefty price tags, IVF providers have little incentive to inform patients of risks, explain Calandrillo and Deliganis. They argue that the United States needs to improve its regulation of assisted reproductive technology.
Fertility clinics use assisted reproductive technology for fertility services. The most common procedures are traditional IVF and intracytoplasmic sperm injection (ICSI). Traditional IVF is a procedure in which a physician retrieves mature eggs from a patient’s ovaries, fertilizes the egg with sperm, and transfers the fertilized egg into a uterus. Many patients prefer IVF over earlier assisted reproduction techniques because IVF procedures are quicker and do not require invasive surgery.
But because IVF only treats female...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...